Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes

The incidence of metabolic disorders, including diabetes, has elevated exponentially during the last decades and enhanced the risk of a variety of complications, such as diabetes and cardiovascular diseases. In the present review, we have highlighted the new insights on the complex relationships between diet-induced modulation of gut microbiota and metabolic disorders, including diabetes. Literature from various library databases and electronic searches (ScienceDirect, PubMed, and Google Scholar) were randomly collected. There exists a complex relationship between diet and gut microbiota, which alters the energy balance, health impacts, and autoimmunity, further causes inflammation and metabolic dysfunction, including diabetes. Faecalibacterium prausnitzii is a butyrate-producing bacterium, which plays a vital role in diabetes. Transplantation of F. prausnitzii has been used as an intervention strategy to treat dysbiosis of the gut’s microbial community that is linked to the inflammation, which precedes autoimmune disease and diabetes. The review focuses on literature that highlights the benefits of the microbiota especially, the abundant of F. prausnitzii in protecting the gut microbiota pattern and its therapeutic potential against inflammation and diabetes.

[1]  Y. Benno,et al.  Effect of Rice Fiber on Human Fecal Microflora , 1989, Microbiology and immunology.

[2]  R. Cichewicz,et al.  The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. , 1996, Journal of ethnopharmacology.

[3]  J. Potter,et al.  Helicobacter pylori--in vitro susceptibility to garlic (Allium sativum) extract. , 1997, Nutrition and cancer.

[4]  L. Brown Helicobacter pylori: epidemiology and routes of transmission. , 2000, Epidemiologic reviews.

[5]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[6]  R. Puupponen-Pimiä,et al.  Berry phenolics selectively inhibit the growth of intestinal pathogens , 2005, Journal of applied microbiology.

[7]  Yuan-Kun Lee,et al.  Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. , 2006, Research in microbiology.

[8]  P. Hsueh,et al.  Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. , 2006, Journal of medical microbiology.

[9]  H. Flint,et al.  Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces , 2006, Applied and Environmental Microbiology.

[10]  H. Alakomi,et al.  Berry Phenolics: Antimicrobial Properties and Mechanisms of Action Against Severe Human Pathogens , 2006, Nutrition and cancer.

[11]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[12]  D. Topping Cereal complex carbohydrates and their contribution to human health , 2007 .

[13]  V. Fogliano,et al.  Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study , 2007, British Journal of Nutrition.

[14]  C. Kwik-Uribe,et al.  Flavanol monomer-induced changes to the human faecal microflora , 2007, British Journal of Nutrition.

[15]  H. Flint,et al.  Understanding the effects of diet on bacterial metabolism in the large intestine , 2007, Journal of applied microbiology.

[16]  H. Flint,et al.  Application of 16S rRNA gene-targetted fluorescence in situ hybridization and restriction fragment length polymorphism to study porcine microbiota along the gastrointestinal tract in response to different sources of dietary fibre. , 2007, FEMS microbiology ecology.

[17]  C. Lebrilla,et al.  Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. , 2008, Nestle Nutrition workshop series. Paediatric programme.

[18]  G. Holtrop,et al.  Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii , 2008, British Journal of Nutrition.

[19]  M. Conlon,et al.  Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. , 2008, FEMS microbiology ecology.

[20]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[21]  M. Lila,et al.  In vitro and in vivo evaluation of the prebiotic activity of water-soluble blueberry extracts , 2009 .

[22]  D. Gibson,et al.  Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice , 2010, Diabetologia.

[23]  J. Doré,et al.  Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.

[24]  G. Casella,et al.  Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model , 2009, The ISME Journal.

[25]  J. Espín,et al.  Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. , 2009, Journal of agricultural and food chemistry.

[26]  J. Kabeerdoss,et al.  Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children , 2009, British Journal of Nutrition.

[27]  E. Medina,et al.  Study of the anti‐lactic acid bacteria compounds in table olives , 2009 .

[28]  J. Bindelle,et al.  Effect of Carbohydrate Composition in Barley and Oat Cultivars on Microbial Ecophysiology and Proliferation of Salmonella enterica in an In Vitro Model of the Porcine Gastrointestinal Tract , 2009, Applied and Environmental Microbiology.

[29]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[30]  C. Frohberg,et al.  A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects , 2010, British Journal of Nutrition.

[31]  Jaehyoung Kim,et al.  Resistant Starches Types 2 and 4 Have Differential Effects on the Composition of the Fecal Microbiota in Human Subjects , 2010, PloS one.

[32]  P. Guilloteau,et al.  From the gut to the peripheral tissues: the multiple effects of butyrate , 2010, Nutrition Research Reviews.

[33]  H. Flint,et al.  Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. , 2010, Environmental microbiology.

[34]  M. Hair-Bejo,et al.  Selected microbial groups and short-chain fatty acids profile in a simulated chicken cecum supplemented with two strains of Lactobacillus. , 2010, Poultry science.

[35]  P. Rutgeerts,et al.  Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. , 2010, The British journal of nutrition.

[36]  G. Gibson,et al.  Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. , 2010, The British journal of nutrition.

[37]  K. Tuohy,et al.  Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study. , 2010, The British journal of nutrition.

[38]  K. Shinohara,et al.  Effect of apple intake on fecal microbiota and metabolites in humans. , 2010, Anaerobe.

[39]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[40]  R. Tyler,et al.  Diets supplemented with chickpea or its main oligosaccharide component raffinose modify faecal microbial composition in healthy adults. , 2010, Beneficial microbes.

[41]  A. Theamboonlers,et al.  Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants. , 2010, Asia Pacific journal of clinical nutrition.

[42]  M. Yannakoulia,et al.  Effect of banana consumption on faecal microbiota: a randomised, controlled trial. , 2011, Anaerobe.

[43]  T. van de Wiele,et al.  Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice , 2011, PloS one.

[44]  W. D. de Vos,et al.  Intestinal microbiota in human health and disease: the impact of probiotics , 2011, Genes & Nutrition.

[45]  J. Bindelle,et al.  Nonstarch polysaccharide-degrading enzymes alter the microbial community and the fermentation patterns of barley cultivars and wheat products in an in vitro model of the porcine gastrointestinal tract. , 2011, FEMS microbiology ecology.

[46]  Patrice D Cani,et al.  Benefits of bariatric surgery: an issue of microbial–host metabolism interactions? , 2011, Gut.

[47]  I. Rowland,et al.  Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects , 2011, British Journal of Nutrition.

[48]  J. Parkhill,et al.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.

[49]  D. Klimis-Zacas,et al.  Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. , 2011, Journal of agricultural and food chemistry.

[50]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[51]  H. Harmsen,et al.  Cultured Representatives of Two Major Phylogroups of Human Colonic Faecalibacterium prausnitzii Can Utilize Pectin, Uronic Acids, and Host-Derived Substrates for Growth , 2011, Applied and Environmental Microbiology.

[52]  Patrice D Cani,et al.  The gut microbiome as therapeutic target. , 2011, Pharmacology & therapeutics.

[53]  Jennifer C. Drew,et al.  Toward defining the autoimmune microbiome for type 1 diabetes , 2011, The ISME Journal.

[54]  B. Weimer,et al.  Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. , 2011, Cell host & microbe.

[55]  G. Nava,et al.  Diversity of the autochthonous colonic microbiota , 2011, Gut microbes.

[56]  F. Guarner,et al.  Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial. , 2012, Nutricion hospitalaria.

[57]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[58]  J. Kabeerdoss,et al.  Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India. , 2012, The British journal of nutrition.

[59]  D. Linetzky Waitzberg,et al.  Microbiota benefits after inulin and partially hydrolized guar gum supplementation: a randomized clinical trial in constipated women. , 2012, Nutricion hospitalaria.

[60]  F. Tinahones,et al.  Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. , 2012, The American journal of clinical nutrition.

[61]  C. Benoist,et al.  The influence of the microbiota on type‐1 diabetes: on the threshold of a leap forward in our understanding , 2012, Immunological reviews.

[62]  K. Zimmermann,et al.  A vegan or vegetarian diet substantially alters the human colonic faecal microbiota , 2012, European Journal of Clinical Nutrition.

[63]  J. Sonnenburg,et al.  Human milk oligosaccharide consumption by intestinal microbiota. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[64]  Michael J. Miller,et al.  Consumption of different soymilk formulations differentially affects the gut microbiomes of overweight and obese men , 2012, Gut microbes.

[65]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[66]  W. D. de Vos,et al.  Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women , 2012, Gut.

[67]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[68]  Congyi Lu,et al.  A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers , 2012, Nutrition Journal.

[69]  Jennifer M. Brulc,et al.  454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. , 2012, The Journal of nutrition.

[70]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[71]  L. Drummond,et al.  Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile , 2012, Microbial ecology in health and disease.

[72]  J. Lecerf,et al.  Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. , 2012, British Journal of Nutrition.

[73]  M. Ferdaoussi,et al.  Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-κB Signalling , 2012, PloS one.

[74]  Patrice D Cani,et al.  Diabetes, obesity and gut microbiota. , 2013, Best practice & research. Clinical gastroenterology.

[75]  T. Wiele,et al.  Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model , 2012, The ISME Journal.

[76]  W. D. de Vos,et al.  Intake of whole-grain and fiber-rich rye bread versus refined wheat bread does not differentiate intestinal microbiota composition in Finnish adults with metabolic syndrome. , 2013, The Journal of nutrition.

[77]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[78]  N. Barnich,et al.  Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation , 2013, Gut.

[79]  P. Hemarajata,et al.  The human gut microbiome and body metabolism: implications for obesity and diabetes. , 2013, Clinical chemistry.

[80]  M. Hattori,et al.  Robustness of Gut Microbiota of Healthy Adults in Response to Probiotic Intervention Revealed by High-Throughput Pyrosequencing , 2013, DNA research : an international journal for rapid publication of reports on genes and genomes.

[81]  A. Andoh,et al.  Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease , 2013, Journal of gastroenterology and hepatology.

[82]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[83]  H. Smidt,et al.  A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. , 2013, The Journal of nutrition.

[84]  G. Gibson,et al.  A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. , 2013, The Journal of nutrition.

[85]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[86]  C. Del Bo’,et al.  Differential modulation of human intestinal bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) drink. , 2013, Journal of agricultural and food chemistry.

[87]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[88]  Zhuye Jie,et al.  Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance , 2013, PloS one.

[89]  L. Ursell,et al.  Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota , 2013, Proceedings of the National Academy of Sciences.

[90]  Aly A. Khan,et al.  Gender bias in autoimmunity is influenced by microbiota. , 2013, Immunity.

[91]  X. Qiu,et al.  Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. , 2013, Journal of Crohn's & colitis.

[92]  F. Tinahones,et al.  Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study , 2013, BMC Medicine.

[93]  M. Anselmino,et al.  Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. , 2013, The Journal of clinical endocrinology and metabolism.

[94]  F. Barkas,et al.  Electrolyte and acid-base disorders in inflammatory bowel disease , 2013, Annals of gastroenterology.

[95]  I. Martínez,et al.  Gut microbiome composition is linked to whole grain-induced immunological improvements , 2012, The ISME Journal.

[96]  D. Stumpo,et al.  LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP. , 2013, Cellular signalling.

[97]  Leah M. Feazel,et al.  Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity , 2013, Science.

[98]  J. Bos,et al.  Exchange protein activated by cAMP 1 (Epac1)‐deficient mice develop β‐cell dysfunction and metabolic syndrome , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  H. Flint,et al.  The influence of diet on the gut microbiota. , 2013, Pharmacological research.

[100]  F. Tinahones,et al.  Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus , 2014, Front. Microbiol..

[101]  H. Flint,et al.  Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. , 2014, International journal of medical microbiology : IJMM.

[102]  H. Zhang,et al.  Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats , 2014, PloS one.

[103]  H. Flint,et al.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota , 2014, The ISME Journal.

[104]  V. Mai,et al.  The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men. , 2014, The Journal of nutrition.

[105]  M. Conlon,et al.  The Impact of Diet and Lifestyle on Gut Microbiota and Human Health , 2014, Nutrients.

[106]  Austin G. Davis-Richardson,et al.  Compromised Gut Microbiota Networks in Children With Anti-Islet Cell Autoimmunity , 2014, Diabetes.

[107]  W. D. de Vos,et al.  Impact of diet on human intestinal microbiota and health. , 2014, Annual review of food science and technology.

[108]  H. Harmsen,et al.  Functional Metabolic Map of Faecalibacterium prausnitzii, a Beneficial Human Gut Microbe , 2014, Journal of bacteriology.

[109]  A. Aydın,et al.  Differences in the gut microbiota of healthy children and those with type 1 diabetes , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[110]  V. Mai,et al.  Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study , 2014, British Journal of Nutrition.

[111]  J. M. Wong Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components. , 2014, The American journal of clinical nutrition.

[112]  E. Zoetendal,et al.  Effect of diet on the intestinal microbiota and its activity , 2014, Current opinion in gastroenterology.

[113]  H. Gaskins,et al.  Influence of dietary fat on intestinal microbes, inflammation, barrier function and metabolic outcomes. , 2014, The Journal of nutritional biochemistry.

[114]  C. Mackay,et al.  Diet, metabolites, and "western-lifestyle" inflammatory diseases. , 2014, Immunity.

[115]  A. Gomes,et al.  Gut microbiota, probiotics and diabetes , 2014, Nutrition Journal.

[116]  R. Bicalho,et al.  Isolation and Characterization of Faecalibacterium prausnitzii from Calves and Piglets , 2014, PloS one.

[117]  J. Cryan,et al.  Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice , 2014, PloS one.

[118]  H. Young,et al.  Does the microbiota play a role in the pathogenesis of autoimmune diseases? , 2014, Gut.

[119]  Guangwei Huang,et al.  Prebiotic effects of almonds and almond skins on intestinal microbiota in healthy adult humans. , 2014, Anaerobe.

[120]  J. Trepanowski,et al.  Fetuin-A: a novel link between obesity and related complications , 2014, International Journal of Obesity.

[121]  M. Sekelja,et al.  Correlation between the human fecal microbiota and depression , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[122]  R. Knight,et al.  Dietary effects on human gut microbiome diversity , 2014, British Journal of Nutrition.

[123]  M. Herieka,et al.  High-fat meal induced postprandial inflammation. , 2014, Molecular nutrition & food research.

[124]  J. Salojärvi,et al.  Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men , 2014, The ISME Journal.

[125]  J. Bodin,et al.  Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[126]  Aiqin Li,et al.  Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation. , 2015, American journal of physiology. Cell physiology.

[127]  C. Pepine,et al.  Gut Dysbiosis Is Linked to Hypertension , 2015, Hypertension.

[128]  Liping Zhao,et al.  Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula , 2014, The ISME Journal.

[129]  H. Flint,et al.  Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease , 2015, Applied and Environmental Microbiology.

[130]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[131]  M. E. Mejía-León,et al.  Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution , 2015, Nutrients.

[132]  G. Ianiro,et al.  Gut barrier in health and disease: focus on childhood. , 2015, European review for medical and pharmacological sciences.

[133]  Y. Xiang,et al.  Association between dietary fiber and lower risk of all-cause mortality: a meta-analysis of cohort studies. , 2015, American journal of epidemiology.

[134]  V. Fulgoni,et al.  Ten-Year Trends in Fiber and Whole Grain Intakes and Food Sources for the United States Population: National Health and Nutrition Examination Survey 2001–2010 , 2015, Nutrients.

[135]  Y. Sanz,et al.  Understanding the role of gut microbiome in metabolic disease risk , 2015, Pediatric Research.

[136]  Xia Li,et al.  The role for gut permeability in the pathogenesis of type 1 diabetes – a solid or leaky concept? , 2015, Pediatric diabetes.

[137]  T. Dinan,et al.  Collective unconscious: how gut microbes shape human behavior. , 2015, Journal of psychiatric research.

[138]  J. Parkhill,et al.  Modulation of the human gut microbiota by dietary fibres occurs at the species level , 2016, BMC Biology.

[139]  D. Frank,et al.  Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes , 2015, Diabetes.

[140]  H. Flint,et al.  Contribution of diet to the composition of the human gut microbiota , 2015, Microbial ecology in health and disease.

[141]  P. Volchkov,et al.  Microbiota regulates type 1 diabetes through Toll-like receptors , 2015, Proceedings of the National Academy of Sciences.

[142]  H. Sokol,et al.  Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.

[143]  H. Sokol,et al.  Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model , 2015, BMC Microbiology.

[144]  J. L. Ding,et al.  GPR41 and GPR43 in Obesity and Inflammation – Protective or Causative? , 2016, Front. Immunol..

[145]  Tamara Zietek,et al.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 , 2016, Front. Immunol..

[146]  T. Dinan,et al.  Gut microbiota, obesity and diabetes , 2016, Postgraduate Medical Journal.

[147]  L. Guan,et al.  The Colonic Microbiome and Epithelial Transcriptome Are Altered in Rats Fed a High-Protein Diet Compared with a Normal-Protein Diet. , 2016, The Journal of nutrition.

[148]  A. Haslberger,et al.  Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects. , 2016, Beneficial microbes.

[149]  C. Goto,et al.  Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes , 2016, Digestion.

[150]  J. Clemente,et al.  The gut microbial community in metabolic syndrome patients is modified by diet. , 2016, The Journal of nutritional biochemistry.

[151]  Brian J. Bennett,et al.  Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk , 2016, Current Diabetes Reports.

[152]  H. Siljander,et al.  The role of the intestinal microbiota in type 1 diabetes mellitus , 2016, Nature Reviews Endocrinology.

[153]  P. Mishra,et al.  Influence of Gut Microbiota on Inflammation and Pathogenesis of Sugar Rich Diet Induced Diabetes , 2016 .

[154]  F. Bäckhed,et al.  Diet–microbiota interactions as moderators of human metabolism , 2016, Nature.

[155]  H. Flint,et al.  Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer , 2016, Inflammatory bowel diseases.

[156]  M. Peppelenbosch,et al.  Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa. , 2016, Journal of Crohn's & colitis.

[157]  Demin Cai,et al.  Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice , 2016, Oncotarget.

[158]  S. Døskeland,et al.  Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression , 2017, Scientific Reports.

[159]  G. Regolisti,et al.  Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease , 2017, Current Diabetes Reports.

[160]  Dean Y. Li,et al.  Endothelial TLR4 and the microbiome drive cerebral cavernous malformations , 2017, Nature.

[161]  S. Delgado,et al.  Bifidobacteria and Their Molecular Communication with the Immune System , 2017, Front. Microbiol..

[162]  R. Wu,et al.  Curcumin attenuates BPA-induced insulin resistance in HepG2 cells through suppression of JNK/p38 pathways. , 2017, Toxicology letters.

[163]  A. Pandey,et al.  Prebiotic Oligosaccharides: Special Focus on Fructooligosaccharides, Its Biosynthesis and Bioactivity , 2017, Applied Biochemistry and Biotechnology.

[164]  J. Diedrich,et al.  Proteomic Analysis of Peripheral Blood Mononuclear Cells after a High-Fat, High-Carbohydrate Meal with Orange Juice. , 2017, Journal of proteome research.

[165]  S. Bibbò,et al.  Is there a role for gut microbiota in type 1 diabetes pathogenesis? , 2017, Annals of medicine.

[166]  V. Azevedo,et al.  Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway , 2017, Front. Microbiol..

[167]  V. Tejnecký,et al.  Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice. , 2017, Beneficial microbes.

[168]  G. Rutter,et al.  A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells , 2017, Diabetes.

[169]  T. Dinan,et al.  The Role of the Gastrointestinal Microbiota in Visceral Pain. , 2017, Handbook of experimental pharmacology.

[170]  C. Hill,et al.  The altered gut microbiota in adults with cystic fibrosis , 2017, BMC Microbiology.

[171]  A. Fodor,et al.  Recent urbanization in China is correlated with a Westernized microbiome encoding increased virulence and antibiotic resistance genes , 2017, Microbiome.

[172]  H. Sokol,et al.  Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic , 2017, Front. Microbiol..

[173]  R. Gearry,et al.  Consumption of kiwifruit capsules increases Faecalibacterium prausnitzii abundance in functionally constipated individuals: a randomised controlled human trial , 2017, Journal of Nutritional Science.

[174]  T. Melgarejo,et al.  Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review. , 2017, Advances in nutrition.

[175]  S. Seino,et al.  Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance , 2016, International Journal of Obesity.

[176]  S. Rampelli,et al.  Variation of Carbohydrate-Active Enzyme Patterns in the Gut Microbiota of Italian Healthy Subjects and Type 2 Diabetes Patients , 2017, Front. Microbiol..

[177]  K. Yam,et al.  Apigenin Impacts the Growth of the Gut Microbiota and Alters the Gene Expression of Enterococcus , 2017, Molecules.

[178]  Junmin Zhang,et al.  Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine , 2018, Drug delivery.

[179]  Yulong Yin,et al.  Gut Microbiota and Type 1 Diabetes , 2018, International journal of molecular sciences.

[180]  E. Want,et al.  In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota , 2018, Front. Microbiol..

[181]  H. Jun,et al.  Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases , 2018, International journal of medical sciences.

[182]  Z. Xun,et al.  Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles , 2018, Front. Microbiol..

[183]  S. Liatis,et al.  Clinical pharmacology of glucagon-like peptide-1 receptor agonists , 2018, Hormones.

[184]  V. Tremaroli,et al.  Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects , 2018, Clinical and Translational Gastroenterology.

[185]  A. Goday,et al.  Influence of the microbiota and probiotics in obesity. , 2018, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[186]  M. Stahl,et al.  Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[187]  Fengna Chu,et al.  Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives , 2018, Mediators of inflammation.

[188]  Xiuqin Fan,et al.  Effects of SCFA on the DNA methylation pattern of adiponectin and resistin in high-fat-diet-induced obese male mice , 2018, British Journal of Nutrition.

[189]  J. Rosenstock,et al.  Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study , 2018, Diabetes, obesity & metabolism.

[190]  O. Werz,et al.  Protective Effect of Casperome®, an Orally Bioavailable Frankincense Extract, on Lipopolysaccharide- Induced Systemic Inflammation in Mice , 2018, Front. Pharmacol..

[191]  S. Duncan,et al.  Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects , 2018, Front. Cell. Infect. Microbiol..

[192]  L. Ferrucci,et al.  Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging. , 2018, The Lancet. Oncology.

[193]  Michael J. Miller,et al.  Catechin supplemented in a FOS diet induces weight loss by altering cecal microbiota and gene expression of colonic epithelial cells. , 2018, Food & function.

[194]  J. de Andrés,et al.  Modulatory effect of three probiotic strains on infants' gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study. , 2018, Beneficial microbes.

[195]  M. Nieuwdorp,et al.  The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes , 2018, Current Diabetes Reports.

[196]  Y. Sun,et al.  LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway. , 2018, European review for medical and pharmacological sciences.

[197]  Xin-huai Zhao,et al.  In vitro activities of inulin fermentation products to HCT-116 cells enhanced by the cooperation between exogenous strains and adult faecal microbiota , 2018, International journal of food sciences and nutrition.

[198]  E. Brzozowska,et al.  The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review , 2018, Molecular Neurobiology.

[199]  Xiaotian Chen,et al.  Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. , 2018, Inflammatory bowel diseases.

[200]  T. Savidge,et al.  Neonatal Colonic Inflammation Epigenetically Aggravates Epithelial Inflammatory Responses to Injury in Adult Life , 2018, Cellular and molecular gastroenterology and hepatology.

[201]  C. Hoffmann,et al.  The human gut microbiota: Metabolism and perspective in obesity , 2018, Gut microbes.

[202]  D. Wishart,et al.  Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. , 2018, American journal of physiology. Endocrinology and metabolism.

[203]  Min Zhou,et al.  Critical regulation of inflammation via class A scavenger receptor , 2018, International journal of chronic obstructive pulmonary disease.

[204]  Philip Strandwitz Neurotransmitter modulation by the gut microbiota , 2018, Brain Research.

[205]  Z. Savin,et al.  Smoking and the intestinal microbiome , 2018, Archives of Microbiology.

[206]  P. Langella,et al.  Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii , 2018, Front. Microbiol..

[207]  G. Coppola,et al.  Microbiota effects on cancer: from risks to therapies , 2018, Oncotarget.

[208]  Bin-Nan Wu,et al.  Eugenosedin‐A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide‐induced diabetic rats , 2018, The Kaohsiung journal of medical sciences.

[209]  Wei Chen,et al.  Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences. , 2018, Food & function.

[210]  G. Baatrup,et al.  Effect of the dietary polyacetylenes falcarinol and falcarindiol on the gut microbiota composition in a rat model of colorectal cancer , 2018, BMC Research Notes.

[211]  E. Volkmann,et al.  Update on the Gastrointestinal Microbiome in Systemic Sclerosis , 2018, Current Rheumatology Reports.

[212]  D. Jain,et al.  Translocation of a gut pathobiont drives autoimmunity in mice and humans , 2018, Science.

[213]  B. Morio,et al.  The Transplantation of ω3 PUFA–Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders , 2018, Diabetes.

[214]  Patrice D Cani,et al.  Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer , 2018, Nature Reviews Gastroenterology & Hepatology.

[215]  Kevin M. Johnson,et al.  Shared and Distinct Features of Human Milk and Infant Stool Viromes , 2018, Front. Microbiol..

[216]  L. McMahon,et al.  The Gut Microbiome as a Therapeutic Target for Cognitive Impairment. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[217]  A. Bitton,et al.  Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography. , 2018, Inflammatory bowel diseases.

[218]  J. Tap,et al.  Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.